EDSA Pardeep Nijhawan buys $67K worth of shares
Mar 03, 2026, 5:35 AM
0.00%
What does EDSA do
Edesa Biotech, headquartered in Markham, Ontario, focuses on developing clinical-stage drugs for inflammatory diseases, including EB05 for ARDS and EB01 for chronic allergic dermatitis. The company employs 16 staff and went public in 2008.
Pardeep Nijhawan bought 30,000 shares of EDSA on 27 February at $2.22 per share, worth a total of $67K. They now own 371,702 EDSA shares, or a 9% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.